When scientists first took the huge leap of deciphering the intricacies of the human genome twelve years ago, the common man benefited in ways unknown to him. And, as more and more data flowed in, the healthcare domain embarked on a new and renewed journey, lead by the field of genomics.
A personalized approach to medicine is now heralded as the new future of healthcare—a unique and defined way to move forward which will not only trim healthcare costs but also improve care by doing away with ineffective treatments. However, while these large scale benefits are yet-to-come, personalized medicine is slowly helping up make the stride from genes to medicines.
The Stagnant Situation Of The Sick
With a reputation of being duped as the home to the world’s largest number of sick people, India is in dire need of major healthcare reforms. After 65 years of independence, most of the excuses (large population, lack of education) are wearing thin, and various chilling examples do nothing but, emphasize a bigger problem.
While primary sicknesses make up a major chunk of the dying population in India, the country also houses a large and diverse population suffering from genetic disorders. And with the growing popularity of individualized treatment, India sure makes the list of investors looking to pile in …show more content…
The lack of knowledge about personalized treatment among the general public as well as doctors, high costs of the treatment, lack of skilled manpower, and longer turnaround times, remain a major restraint for market growth. In order to change this scenario, the government needs to devise a coherent plan—one which encompasses increasing partnerships with pharmaceutical, medical devices and diagnostics companies to promote research, and educating both the healthcare providers, and the public of how personalized medicine can change their future for
A personalized approach to medicine is now heralded as the new future of healthcare—a unique and defined way to move forward which will not only trim healthcare costs but also improve care by doing away with ineffective treatments. However, while these large scale benefits are yet-to-come, personalized medicine is slowly helping up make the stride from genes to medicines.
The Stagnant Situation Of The Sick
With a reputation of being duped as the home to the world’s largest number of sick people, India is in dire need of major healthcare reforms. After 65 years of independence, most of the excuses (large population, lack of education) are wearing thin, and various chilling examples do nothing but, emphasize a bigger problem.
While primary sicknesses make up a major chunk of the dying population in India, the country also houses a large and diverse population suffering from genetic disorders. And with the growing popularity of individualized treatment, India sure makes the list of investors looking to pile in …show more content…
The lack of knowledge about personalized treatment among the general public as well as doctors, high costs of the treatment, lack of skilled manpower, and longer turnaround times, remain a major restraint for market growth. In order to change this scenario, the government needs to devise a coherent plan—one which encompasses increasing partnerships with pharmaceutical, medical devices and diagnostics companies to promote research, and educating both the healthcare providers, and the public of how personalized medicine can change their future for